Skip to main content

and
  1. Article

    Open Access

    Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer

    Gastric cancer is a fatal gastrointestinal cancer with high morbidity and poor prognosis. The dismal 5-year survival rate warrants reliable biomarkers to assess and improve the prognosis of gastric cancer. Dis...

    Nannan Liu, Yun Wu, Weipeng Cheng, Yuxuan Wu, Liguo Wang, Liwei Zhuang in BMC Cancer (2021)

  2. No Access

    Article

    Plasma cell-free DNA-based predictors of response to abiraterone acetate/prednisone and prognostic factors in metastatic castration-resistant prostate cancer

    The combination of abiraterone acetate and prednisone (AA/P) is used to treat metastatic prostate cancer, but molecular predictors of treatment response are not well elucidated. We evaluated plasma circulating...

    Meijun Du, Yijun Tian, Winston Tan, Liewei Wang in Prostate Cancer and Prostatic Diseases (2020)

  3. No Access

    Article

    Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients

    The prognostic significance of plasma cell-free DNA (cfDNA) androgen receptor amplification (ARamp) in metastatic castration-resistant prostate cancer (mCRPC) compared with circulating tumor cell (CTC) counts is ...

    Manish Kohli, Jian Li, Meijun Du, David W Hillman in Prostate Cancer and Prostatic Diseases (2018)

  4. No Access

    Article

    Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT–mTORC1 activation

    Mutations in SPOP, the gene encoding a component of the E3 ubiquitin ligase complex, impair ubiquitination-dependent degradation of BRD2, BRD3 and BRD4 proteins and result in activation of ATK–mTORC1 signaling an...

    **zhao Zhang, Dejie Wang, Yu Zhao, Shancheng Ren, Kun Gao, Zhenqing Ye in Nature Medicine (2017)